Plasma tenascin-C level as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy

被引：0
|
作者：
Kitaoka, H. [1 ]
Kubo, T. [1 ]
Baba, Y. [1 ]
Yamasaki, N. [1 ]
Matsumura, Y. [1 ]
Furuno, T. [1 ]
Doi, Y. [1 ]
机构：
[1] Kochi Med Sch, Kochi, Japan
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：592 / 592
页数：1
相关论文
共 50 条
  • [41] Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics
    Lumish, Heidi S.
    Liang, Lusha W.
    Hasegawa, Kohei
    Maurer, Mathew S.
    Fifer, Michael A.
    Reilly, Muredach P.
    Shimada, Yuichi J.
    HEART, 2023, 109 (24) : 1837 - 1843
  • [42] Endothelial Cell-Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients with Hypertrophic Cardiomyopathy
    Tamura, Shogo
    Akita, Keitaro
    Fifer, Michael
    Rader, Albree Tower
    Maurer, Mathew
    Reilly, Muredach
    Shimada, Yuichi
    CIRCULATION, 2024, 150
  • [43] Effects of carvedilol and metoprolol on intraventricular dyssynchrony and Tenascin-C values in patients with idiopathic dilated cardiomyopathy
    Kaya, M. G.
    Sarli, B.
    Lam, Y. Y.
    Kaya, E. G.
    Ozdogru, I.
    Kalay, N.
    Yarlioglues, M.
    Topsakal, R.
    EUROPEAN HEART JOURNAL, 2010, 31 : 574 - 575
  • [44] Genotype-Positive Status in Patients With Hypertrophic Cardiomyopathy Is Associated With Higher Rates of Heart Failure Events
    Li, Qin
    Gruner, Christiane
    Chan, Raymond H.
    Care, Melanie
    Siminovitch, Katherine
    Williams, Lynne
    Woo, Anna
    Rakowski, Harry
    CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (04) : 416 - 422
  • [45] Progressive Heart Failure is Uncommon in Patients With Nonobstructive Hypertrophic Cardiomyopathy
    Rowin, Ethan J.
    Maron, Barry J.
    Olivotto, Iacopo
    Casey, Susan A.
    Arretini, Anna
    Tomberli, Benedetta
    Garberich, Ross
    Link, Mark S.
    Chan, Raymond H.
    Appelbaums, Evan
    Lesser, John R.
    Udelson, James E.
    Maron, Martin S.
    CIRCULATION, 2013, 128 (22)
  • [46] SIGNIFICANCE OF MYOCARDIAL TENASCIN-C EXPRESSION IN ASSOCIATION WITH INFILTRATIVE INFLAMMATORY CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY
    Sugano, Yasuo
    Nakayama, Takafumi
    Yokokawa, Tetsuro
    Nagai, Toshiyuki
    Kanzaki, Hideaki
    Matsuyama, Taka-aki
    Ohta-Ogo, Keiko
    Ikeda, Yoshihiko
    Tshibashi-Ueda, Hatsue
    Nakatani, Takeshi
    Yasuda, Satoshi
    Ogawa, Hisao
    Anzai, Toshihisa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A995 - A995
  • [47] The Outcome Of Acute Heart Failure In Patients With Hypertrophic Obstructive Cardiomyopathy
    Amoah, Joseph
    Noureldin, Sara
    Smith, Brittany
    Dekowski, Samir
    Fatuyi, Michael
    Somoza-Cano, Francisco
    Arueyingho, Alero
    Illah, Catherine
    Egbuchiem, Henry
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 186 - 187
  • [48] SEX DIFFERENCES IN HEART FAILURE HOSPITALIZATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    Oluleye, Oludamilola
    Duval, Sue
    Jain, Renuka
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A846 - A846
  • [49] Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure
    Nguyen, Anita
    Schaff, Hartzell, V
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Dearani, Joseph A.
    King, Katherine S.
    Ommen, Steve R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (01): : 145 - 152
  • [50] TREATMENT OF CONGESTIVE HEART-FAILURE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    HESS, OM
    KRAYENBUHL, HP
    THERAPEUTISCHE UMSCHAU, 1984, 41 (02) : 138 - 141
12345